NEW DELHI, April 28: Serum Institute of India (SII) — the maker of the most used COVID-19 vaccine in the country — on Wednesday announced a cut in price of the jab it plans to sell to states to Rs 300 per dose from the earlier Rs 400. This follows widespread criticism of its pricing policy as it has sold the initial doses of Covishield to the central government at Rs 150 per dose. SII’s CEO Adar Poonawalla took to Twitter to announce the “philanthropic” gesture.
About Us
The Shillong Times first appeared as a tabloid weekly on 10th August 1945 under the editorship of Late Sudhindra Bhusan Chaudhuri. In 1958 it was converted to a Daily. Owing to financial constraints, within six months it reverted back to a weekly.
Latest news
Will end naxalism in Chhattisgarh by March 2026: Amit Shah
Raipur, Dec 15: Union Home Minister Amit Shah on...
Hindu leaders demand apology from Rahul Gandhi on Dronacharya-Eklavya remark
New Delhi, Dec 15 : As Leader of Opposition...
Parliamentarians unite over cricket match, raise awareness about eradicating TB by 2025
New Delhi, Dec 15 : In a unique blend...
Popular news
Will end naxalism in Chhattisgarh by March 2026: Amit Shah
Raipur, Dec 15: Union Home Minister Amit Shah on...
Hindu leaders demand apology from Rahul Gandhi on Dronacharya-Eklavya remark
New Delhi, Dec 15 : As Leader of Opposition...
Parliamentarians unite over cricket match, raise awareness about eradicating TB by 2025
New Delhi, Dec 15 : In a unique blend...
© 2024 The Shillong Times. All Rights Reserved | Crafted with IndoAge